Boston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference

MARLBOROUGH, Mass., Aug. 1, 2016 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th Annual Canaccord Genuity Growth Conference on August 11 in Boston and the 2016 Wedbush PacGrow Healthcare Conference on August 16 in New York.

Susie Lisa, vice president, and Justin Castelli, senior manager, Investor Relations, will participate in a 25-minute question-and-answer session with the Canaccord Genuity host analyst beginning at approximately 8:30 a.m. ET on August 11, and a 30-minute question-and-answer session with the Wedbush PacGrow host analyst beginning at approximately 10:20 a.m. ET on August 16.

Live webcasts of both question-and-answer sessions will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start times to ensure a timely connection.

A replay of each webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

 

CONTACTS


Media:                          

Investors:

Tom Keppeler                      

Susie Lisa, CFA

508-683-6585 (office)                 

508- 683-5565 (office)

Media Relations                       

Investor Relations

Boston Scientific Corporation          

Boston Scientific Corporation

thomas.keppeler@bsci.com            

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation

Top